Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Amortization of Deferred Charges (2016 - 2026)

Aytu Biopharma has reported Amortization of Deferred Charges over the past 7 years, most recently at $29000.0 for Q4 2025.

  • Quarterly Amortization of Deferred Charges rose 3.57% to $29000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $111000.0 through Dec 2025, down 68.29% year-over-year, with the annual reading at $108000.0 for FY2025, 81.91% down from the prior year.
  • Amortization of Deferred Charges was $29000.0 for Q4 2025 at Aytu Biopharma, roughly flat from $29000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $170000.0 in Q4 2022 and troughed at -$165000.0 in Q4 2021.
  • The 5-year median for Amortization of Deferred Charges is $98000.0 (2023), against an average of $56789.5.
  • Year-over-year, Amortization of Deferred Charges plummeted 451.06% in 2021 and then skyrocketed 203.03% in 2022.
  • A 5-year view of Amortization of Deferred Charges shows it stood at -$165000.0 in 2021, then skyrocketed by 203.03% to $170000.0 in 2022, then fell by 9.41% to $154000.0 in 2023, then plummeted by 81.82% to $28000.0 in 2024, then rose by 3.57% to $29000.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Amortization of Deferred Charges are $29000.0 (Q4 2025), $29000.0 (Q3 2025), and $26000.0 (Q2 2025).